Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Oncogene, 2026

FATP5 loss in hepatocellular carcinoma cells orchestrates tumor-promoting microenvironment by inducing passive long-chain fatty acid accumulation within tumor-associated endothelial cells

Fu C., Fu W., Zhao Z. et al.

Immunobiology, 2026

Anti-CD20 mediated B cell depletion exerts a distinct influence on T cell immunity by decreasing effector memory CD4 Th17 and Th1.17 subsets in multiple sclerosis

Evertsson B., Ruffin N., Theorell J. et al.

Kidney International, 2026

Peritoneal dialysis induces hepatic metabolic stress as an instigator for systemic inflammation

Eibensteiner F., Herzog R., Trauner M. et al.

npj Vaccines, 2026

Coordinated serum interferon gamma and IL-15 responses to PfRAS vaccination are associated with protection from malaria

Duffy F., Götz A., Windle S. et al.

Frontiers in Immunology, 2026

Multi-source analysis identifies an NPC2-associated macrophage transcriptional program in ulcerative colitis

Chen Y., Yang W., Wang K. et al.

Genes, 2026

Epithelial Alternative Polyadenylation Identifies Hepatoma-Derived Growth Factor as a Genetically Supported Candidate in Prostate Cancer

Chen H., Wang R., Zhao Z. et al.

Frontiers in Medicine, 2026

Proteomics-based immune activation signatures are associated with kidney allograft rejection

Schröter I., Loi L., Rudek M. et al.

Brain, Behavior, and Immunity, 2026

Serum proteomic correlates of arts and cultural engagement and their associations with health outcomes: cross-sectional and longitudinal analyses in the UK Household Longitudinal Study

Qin P., Finn S., Fancourt D.

Hepatology Communications, 2026

Distinct immune signatures define hepatitis D– versus hepatitis B–associated hepatocellular carcinoma

Glimmann S., Deterding K., Bock K. et al.

Scientific Reports, 2026

Changes in circulating biomarkers in symptomatic atrial fibrillation from before to one day after catheter ablation

Jackson A., Fröbert O., Boye Larsen D. et al.

BMJ Public Health, 2026

Night-shift work and risk of incident musculoskeletal disorders: a prospective cohort study with proteomic mediation analysis in the UK Biobank

Fan W., Kong K., Jin F. et al.

Scientific Reports, 2026

Stem cell secretome-enriched hydrogels as a potential therapeutic approach for osteoarthritis

Casado-Santos A., Vilariño-Feltrer G., González-Rodríguez Y. et al.

Blood Immunology & Cellular Therapy, 2026

Plasma proteomics reveals a low-expression immune phenotype in long-term pediatric hematopoietic cell transplantation survivors

Wieringa N., Asbroek L., Müskens K. et al.

American Journal of Physiology-Cell Physiology, 2026

Characterization of von Willebrand Factor-Enriched Extracellular Vesicles and Their Association with Platelet Adhesion in COVID-19

Chen L., Mahajan A., Kumar Ram A. et al.

Physiological Genomics, 2026

Cell-free genome analysis reveals pathophysiological response to hypoxia at high altitude

Choudhary R., Ali M., G K. et al.

Journal of Translational Medicine, 2026

Multimodal fusion prediction model based on prospective plasma proteomics: preclinical risk prediction and key pathway analysis of rheumatoid arthritis

Wang T., Wang L., Zhang H. et al.

Journal of Proteome Research, 2026

Identification of Biomarkers for Precancerous Colorectal Lesions Utilizing Olink Proteomics and Colorectal Cancer Animal Models

Fu X., Jian R., Xu X. et al.

Journal of Global Health, 2026

Multidimensional sleep health: risk of cardiovascular disease and mortality, and mediation by plasma proteins

Wei Z., Xiao Q., Wang S. et al.

Brain, Behavior, & Immunity - Health, 2026

Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection

Ueland T., Cox R., Michelsen A. et al.

Archives of Gerontology and Geriatrics, 2026

Associations between infection and organ age gaps: results from the UK Biobank

Shi Y., Wang M., Zhao S. et al.

4711 publications